WVE insider plans Rule 144 sale of 1,870 shares

Chris Francis has filed a notice of proposed share sales under Rule 144 for Wave Life Sciences (symbol WVE).

Rhea-AI Filing Summary

Chris Francis has filed a notice of proposed share sales under Rule 144 for Wave Life Sciences (symbol WVE). The filing covers 1,870 ordinary shares to be sold through Morgan Stanley Smith Barney LLC on or about 02/09/2026 on NASDAQ, with an aggregate market value of 25,151.50 and 187,693,059 ordinary shares outstanding.

The 1,870 shares were acquired on 02/08/2026 through restricted stock unit vesting from the issuer as equity compensation. In the past three months, Francis has already sold 441,031 ordinary shares on 12/08/2025 for gross proceeds of 6,427,084.96 and 9,375 ordinary shares on 01/02/2026 for 150,260.10.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the WVE Rule 144 filing by Chris Francis disclose?

The filing discloses that Chris Francis plans to sell 1,870 WVE ordinary shares under Rule 144. These shares were acquired via restricted stock unit vesting on 02/08/2026 as equity compensation from the issuer, with planned sales through Morgan Stanley Smith Barney LLC on NASDAQ.

How many WVE shares is Chris Francis currently planning to sell?

Chris Francis is planning to sell 1,870 WVE ordinary shares. The planned sale has an aggregate market value of 25,151.50 and is expected to occur around 02/09/2026 on NASDAQ, using Morgan Stanley Smith Barney LLC as the broker for the transaction.

How were the 1,870 WVE shares in the Rule 144 notice acquired?

The 1,870 WVE ordinary shares were acquired on 02/08/2026 through restricted stock unit vesting. The issuer granted these shares as equity compensation, and the filing lists the issuer as the source, with the transaction classified as equity compensation rather than a cash purchase.

What WVE share sales has Chris Francis made in the last three months?

Over the past three months, Chris Francis sold 441,031 ordinary shares of WVE on 12/08/2025 for gross proceeds of 6,427,084.96 and 9,375 ordinary shares on 01/02/2026 for 150,260.10. These historical sales are disclosed alongside the new planned Rule 144 sale.

What does the WVE Rule 144 filing say about total shares outstanding?

The filing states that 187,693,059 WVE ordinary shares were outstanding. This figure provides context for the planned sale of 1,870 shares under Rule 144, showing the relative size of the proposed transaction compared with the issuer’s total ordinary shares outstanding.

Which broker will handle Chris Francis’s planned sale of WVE shares?

The planned sale of 1,870 WVE ordinary shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s listed address is 1 New York Plaza, 8th Floor, New York, NY 10004, and the shares are expected to be sold on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/09/2026 - 09:29 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001657709
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Wave Life Sciences Ltd.
SEC File Number	001-37627
Address of Issuer	7 Straits View #12-00 Marina One East Tower Singapore SINGAPORE 18936
Phone	65-6236 3388
Name of Person for Whose Account the Securities are To Be Sold	Chris Francis
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
ordinary shares	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	1870	25151.50	187693059	02/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
ordinary shares	02/08/2026	Restricted Stock Unit Vesting	ISSUER			1870	02/08/2026	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Chris Francis 733 Concord Ave. Cambridge MA 02138	Ordinary Shares	12/08/2025	441031	6427084.96
Chris Francis 733 Concord Ave. Cambridge MA 02138	Ordinary Shares	01/02/2026	9375	150260.10

144: Remarks and Signature

Remarks	These sales were made pursuant to a provision in the reporting person's RSU agreement that requires automatic sales of shares to cover tax withholding obligations.
Date of Notice	02/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Chris Francis
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)